1-10 of 10
Micaela Ippoliti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy.

Monica Bocchia, Marzia Defina, Micaela Ippoliti, Elisabetta Abruzzese, Fausto Castagnetti, Mario Tiribelli, Gianantonio Rosti, Massimo Breccia, MD, Malgorzata Monika Trawinska, Rosaria Crupi, Lara Aprile, Marzia Salvucci, Claudia Baratè, Antonella Gozzini, Michela Rondoni, Alfonso Zaccaria, Giuliana Alimena, MD, Valeria Santini, Giorgina Specchia, Renato Fanin, Alessandro Gozzetti, Francesco Lauria, MD
Journal: Blood
Blood (2010) 116 (21): 3413.
https://doi.org/10.1182/blood.V116.21.3413.3413
Published: 2010
Journal Articles

BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial.

Monica Bocchia, Marzia Defina, Micaela Ippoliti, Marilina Amabile, Massimo Breccia, Francesco Iuliano, Marco Vignetti, Gabriele Gugliotta, Antonella Russo Rossi, Giuliana Alimena, Lara Aprile, Gianluca Gaidano, Paolo Nicoli, Malgorzata Monika Trawinska, Renato Bassan, Diamante Turri, Laura Cannella, Luigia Luciano, Alessandro Gozzetti, Michela Rondoni, Gianantonio Rosti, Giovanni Martinelli, Michele Baccarani, MD, Francesco Lauria, MD
Journal: Blood
Blood (2009) 114 (22): 648.
https://doi.org/10.1182/blood.V114.22.648.648
Published: 2009
Journal Articles

Peptide-Vaccine Treatment Associated with TKI Therapy in Patients with CML Is Able to Induce Immunologic, Cytogenetic and Molecular Responses: a Single Center Experience with Long-Term Follow up.

Elisabetta Abruzzese, Malgorzata Monika Trawinska, Angela Coletta, Serena Zaza, Roberta Giovagnorio, Giovanni Del Poeta, Micaela Ippoliti, Delfina Marzia, Paolo de Fabritiis, Francesco Lo Coco, Sergio Amadori, Monica Bocchia
Journal: Blood
Blood (2009) 114 (22): 2185.
https://doi.org/10.1182/blood.V114.22.2185.2185
Published: 2009
Journal Articles

CMLVAX100 Peptide Vaccinations induce Peptide Specific “cytotoxic” CD4+ T Cells (CD4+CTLs) in Chronic Myeloid Leukemia Patients: New Insights about Peptide Vaccine-Mediated Antitumor Response

Monica Bocchia, Maristella Tassi, Micaela Ippoliti, Marzia Defina, Elisabetta Abruzzese, Malgorzata Monika Trawinska, Alessandro Gozzetti, Donatella Raspadori, Francesco Lauria
Journal: Blood
Blood (2008) 112 (11): 3209.
https://doi.org/10.1182/blood.V112.11.3209.3209
Published: 2008
Journal Articles

Two Novel WT-1 Derived Peptides Induce CD4+ peptide–specific T Cell Proliferation in Patients with Myelodysplastic Syndrome (MDS)

Monica Bocchia, Micaela Ippoliti, Marzia Defina, Rosaria Crupi, Maristella Tassi, Michela Rondoni, Alessandro Gozzetti, Francesco Lauria
Journal: Blood
Blood (2008) 112 (11): 5432.
https://doi.org/10.1182/blood.V112.11.5432.5432
Published: 2008
Journal Articles

Low Dose Rituximab in Adult Patients with Idiopathic Thrombocytopenic Purpura.

Francesco Zaja, Marta L. Battista, Maria T. Pirrota, Salvatore Palmieri, Michela Montagna, Nicola Vianelli, Margherita Cavallin, Monica Bocchia, Marzia Defina, Micaela Ippoliti, Felicetto Ferrara, Francesca Patriarca, Maria A. Avanzini, Mario Regazzi, Miriam Isola, Franca Soldano, Michele Baccarani, Renato Fanin
Journal: Blood
Blood (2007) 110 (11): 1305.
https://doi.org/10.1182/blood.V110.11.1305.1305
Published: 2007
Journal Articles

Characterization of CD4 + T Cell Response Induced by p210-Derived Peptide Vaccinations in CML Patients.

Monica Bocchia, MD, Micaela Ippoliti, P.h.D, Elisabetta Abruzzese, M.D., Maristella Tassi, P.h.D, Marzia Defina, M.D., Malgorzata M. Trawinska, M.D., Alessandro Gozzetti, M.D., Donatella Raspadori, P.h.D, Francesco Lauria, M.D.
Journal: Blood
Blood (2007) 110 (11): 1808.
https://doi.org/10.1182/blood.V110.11.1808.1808
Published: 2007
Journal Articles

Evaluation of Ph+/CD34+ Residual Cells in Chronic Myeloid Leukemia Patients after Long Lasting Treatment with Imatinib Mesylate.

Monica Bocchia, MD, Elisabetta Abruzzese, MD, Micaela Ippoliti, PhD, Simona Calabrese, BS, Alessandro Gozzetti, MD, Maria Teresa Pirrotta, MD, Rosaria Crupi, BS, Daniela Tozzuoli, PhD, Francesco Lauria, MD
Journal: Blood
Blood (2005) 106 (11): 1999.
https://doi.org/10.1182/blood.V106.11.1999.1999
Published: 2005
Journal Articles

Control of Residual Disease in Imatinib Treated Chronic Myeloid Leukemia Patients with Peptide Vaccinations: 2 Years Follow up of CMLVAX100 Trial.

Monica Bocchia, MD, Elisabetta Abruzzese, MD, Micaela Ippoliti, PhD, Maria Teresa Pirrotta, MD, Malgorzata M. Trawinska, MD, Marilina Amabile, PhD, Giovanni Martinelli, MD, Francesco Forconi, MD, Alessandro Gozzetti, MD, Angelo M. Carella, MD, Donatella Raspadori, PhD, Francesco Lauria, MD
Journal: Blood
Blood (2005) 106 (11): 167.
https://doi.org/10.1182/blood.V106.11.167.167
Published: 2005
Journal Articles

Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch

Francesco Forconi, Surinder S. Sahota, Donatella Raspadori, Micaela Ippoliti, Gavin Babbage, Francesco Lauria, Freda K. Stevenson
Journal: Blood
Blood (2004) 104 (10): 3312–3317.
https://doi.org/10.1182/blood-2004-03-0950
Published: 2004